Revenue Guidance

 
News Articles for Revenue Guidance top ^
2015/1/13
Full-Year 2014 Home Revenue Projected to Increase Approximately 18% LAWRENCE, Mass.
Sign-up for NxStage Increases Revenue Guidance for the Fourth Quarter and Full-Year 2014 investment picks
2015/1/29
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1172223&ProfileId=051205&sourceType=1 MENLO PARK, CA --
Sign-up for Corcept Therapeutics Announces Fourth Quarter and Full Year 2014 Revenue, Provides 2015 Revenue Guidance and Clinical Update investment picks
2014/12/10
INCLINE VILLAGE, Nev.
Sign-up for PDL BioPharma Provides Fourth Quarter 2014 Revenue Guidance of $158 Million investment picks
2015/1/22
Company Now Projecting 36% Year-Over-Year Revenue Growth in Quarter 4 FT.
Sign-up for NeoGenomics Raises Revenue Guidance to $25 Million and EPS Guidance to $0.01 - $0.02 per share for Quarter 4, 2014 investment picks
2015/1/6
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1167576&ProfileId=051205&sourceType=1 FOSTER CITY, CA --
Sign-up for SciClone Provides 2014 Financial Update and 2015 Revenue Guidance investment picks
2015/2/5
By Angela Chen Becton Dickinson Co.
Sign-up for Becton Dickinson Raises Revenue Guidance as Strong Flu Season Boosts Results -- Update investment picks
2015/1/20
Subhead of release should read: Company to host a Conference Call and Webcast on Wednesday, February 25th beginning at 10:00 a.m. EST to report 4Q and FY2014 Financial Results (instead of Monday, February 25th). Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX), a specialty pharmaceutical company, today announced that based on a preliminary review of 2014 fourth quarter results it expects Net Revenue to exceed FY2014 guidance.
Sign-up for CORRECTING and REPLACING Pernix Therapeutics Exceeds 2014 Revenue Guidance: Delivers FY2014 Net Revenue In Excess of $120 Million investment picks
2015/1/12
SHENZHEN, China , Jan.
Sign-up for Mindray Announces Preliminary 2014 Operating Results and 2015 Net Revenues Guidance investment picks
2015/2/4
Project charge reduces second quarter earnings per share by $0.29 to $0.12 Exclusive of project charge, Company experiences strong margin performance across all segments Revenue increases from the first to second quarter lead to higher absorption of construction overhead costs Year-to-date project awards total $587.7 million excluding recently announced construction award for TransCanada's Napanee Generating Station TULSA, Okla., Feb.
Sign-up for Matrix Service Company Announces Second Quarter Results; Maintains Revenue Guidance, Lowers Earnings Guidance Due to a Project Charge investment picks
2015/1/14
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1168950&ProfileId=051205&sourceType=1 ALISO VIEJO, CA --
Sign-up for Smith Micro Reports Preliminary Q4 2014 Revenue and Profits; Provides Revenue Guidance for Fiscal 2015 investment picks
2015/1/13
Fluidigm Corporation (NASDAQ:FLDM) today announced total revenue for the fourth quarter of 2014 is expected to be approximately $33.4 million based on preliminary, unaudited financial data.
Sign-up for Fluidigm Announces Preliminary Fourth Quarter 2014 Revenue and Issues 2015 Revenue Guidance investment picks
2014/12/4
SAN JOSE, Calif.
Sign-up for Synaptics Announces Retirement of CFO; Raises Second Quarter Fiscal 2015 Revenue Guidance investment picks
2015/1/8
FORT WORTH, Texas, Jan.
Sign-up for Tandy Leather Factory, Inc. Beats 2014 Revenue Guidance With Strong December Sales Gain of 18% investment picks

Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Revenue Guidance
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap

Previous: Revenue Growth  |  Next: Revenue Guidance for the Year